Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2003
09/09/2003US6617437 Modified oligonucleotide of given formula; useful in diagnostics and therapeutics
09/09/2003US6617332 Cyclic amidinourea derivatives
09/09/2003US6617330 For controlling and preventing pests
09/09/2003US6617281 Substituted acylamino phenyl uracils
09/09/2003CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
09/09/2003CA2228655C Preparation of triazoles by organometallic addition to ketones
09/09/2003CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity
09/04/2003WO2003072551A1 Uracil-thioether
09/04/2003WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072139A1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
09/04/2003WO2003072108A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
09/04/2003WO2003022790A3 Biphenylene compounds
09/04/2003US20030166961 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative
09/04/2003US20030166933 Contacting with alkali metal alkoxide in alcohol
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166647 Nitrogen compounds such as 5-(4-(Benzyloxy)benzyl)-5-methyl-2, 4,6(1H,3H,5H)-pyrimidinetrione, used as enzyme inhibitors, used as antiinflammatory agents
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
09/04/2003CA2833470A1 Processes for preparing form 1 zd1839 polymorph
09/04/2003CA2702297A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2477350A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003CA2477287A1 Uracil-thioether
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/03/2003EP1340748A1 Quinazoline derivatives and drugs
09/03/2003EP1339699A1 Substituted amidoalkyl uracils and the use thereof
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339409A1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
09/03/2003EP1214300B1 Rate-controlled particles
09/03/2003EP1131319B1 3- benz(ox/thi)azol-7-yl -1h-pyrimidine-2,4-diones
09/03/2003EP1038861B1 4-fluoro-3-oxocarboxylic esters and process for producing the same
09/03/2003EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440398A Substituted phthalides as anti-convulsive drugs
09/03/2003CN1440393A Cyclic compounds
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/02/2003US6614719 Ultrasonic doppler effect speed measurement
09/02/2003US6613803 Treating, preventing or ameliorating pain
09/02/2003US6613782 For treating and/or preventing endothelin dependent conditions, e.g. cardio- and cerebro-vascular disorders such as hypertension, vasoconstriction, congestive heart failure, cerebral disorders, respiratory system disorders
09/02/2003US6613773 Pyrimidinyloxyphenyl-3-alkoxypropenoates derivatives
09/02/2003US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
09/02/2003US6613771 Prevent human retroviral reproduction, infections
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613718 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
09/02/2003US6613245 Crosslinkable liquid crystalline compounds
09/02/2003CA2216796C Quinazoline derivatives
08/2003
08/28/2003WO2003070709A1 Novel phenylalanine derivative
08/28/2003WO2003070708A1 Method for producing 2-anilino-4,6-dimethylpyrimidine
08/28/2003WO2003070701A2 Syntheses of quinazolinones
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003WO2003028641A3 Mch receptor antagonists
08/28/2003WO2002000638A8 Substituted phthalides as anti-convulsive drugs
08/28/2003US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa
08/28/2003US20030162799 Squaric acid derivatives
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162774 Derivatives of sulfonylurea, sulfonylthiourea, sulfonylguanidine, thioacylsufonamide and acylsulfonamide; useful for treating thromobis
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003CA2475879A1 Synthesis of quinazolinones
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/27/2003EP1337218A2 Substituted felbamate derived compounds
08/27/2003EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP1036794B1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003CN1438994A Polymorphic forms/hydrates of N-[4-(3-chloro-4-fluoro-phenylamino)-7- (3-morpholin-4-ylpropoxy)-quinazolin-6-Yl] acrylamide dihydrochloride
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438887A 水性液体制剂 The aqueous liquid preparation
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/26/2003US6610882 Affinity for bradykinin receptors; antithrombotics
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610846 Heteroaromatic glucokinase activators
08/26/2003US6610747 Phenoxybenzylamine derivatives as SSRIs
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis.
08/26/2003US6610698 Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases
08/26/2003US6610691 Carboxylic acid derivatives, their production and use
08/26/2003US6610678 Corticotropin-releasing factor antagonists; treating endocrine, psychiatric or neurologic disorders
08/26/2003US6610660 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610518 Using Cytochrome p450
08/26/2003US6610269 Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068767A1 Pyrimidines as novel openers of potassium ion channels
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068757A1 Novel pyridin- and pyrimidin-derivatives
08/21/2003WO2003068242A1 Phospholipids as caspase inhibitor prodrugs
08/21/2003WO2002094844A3 Antiviral nucleosides
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158408 One-pot reaction for making enzyme inhibitors of epidermal growth factor receptor tyrosine kinase, antitumor agents
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003US20030158207 N-benzylpiperazine compounds
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 427